NeoKare Nutrition Ltd, a manufacturer in human milk-based formulations, recently announces the launch of NeoKare MMF in the UK, the world’s first mother’s milk fortifier in powder form.
In the UK, between 52,000 [i] and 60,000[ii] babies are born prematurely every year. Premature birth is the leading cause of morbidity and mortality in neonates[iii] and optimal nutrition plays a critical role in a premature baby’s survival [iv]. As per 2017 WHO Recommendations on newborn health, very low birth weight infants who fail to gain weight, despite adequate breast milk feeding, should be given fortifiers, preferably those that are human milk based.[v]
NeoKare’s MMF is the world’s first and only powdered milk fortifier made from human milk provided by breast feeding mothers, as opposed to bovine based products. NeoKare MMF meets the European Society for Paediatric Gastroenterology Hepatology and Nutrition’s (ESPGHAN) guidelines on energy and protein content. Our advanced technology retains most of the oligosaccharides and other micronutrients needed by newborns.
NeoKare’s MMF, when added to mothers’ milk, provides the enhanced nutrition necessary for premature infants, which cannot be provided by mothers’ milk alone. NeoKare MMF is supplementary to and does not displace mothers’ milk. NeoKare MMF is a product designed for use in a hospital setting.
An exclusive human milk diet in premature infants (a human milk-based fortifier combined with mothers’ own or donor milk) has been shown to reduce the rates of surgical necrotising enterocolitis (NEC)iv and mortality, as well a reduction in late-onset sepsis, bronchopulmonary dysplasia (BPD), and retinopathy of prematurity (ROP)v.
Milk provided by mothers, is subject to NeoKare’s collection procedures, which are aligned with the National Institute for Health